$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is the targeted drug venetoclax/venetoclax produced or sold in India?
2026-02-01 22:25:32
Check Details
How long will it take for the blood indicators to recover after using venetoclax/venetoclax?
2026-02-01 22:25:32
Check Details
Wide range of therapeutic applications for venetoclax/venetoclax
2026-02-01 22:25:32
Check Details
How much does the generic version of Osimertinib (Tagressa) cost?
2026-02-01 22:25:32
Check Details
How much does a box of generic Osimertinib (Tagressa) cost?
2026-02-01 22:25:32
Check Details
What is the mechanism of action of Osimertinib (Tagressa)?
2026-02-01 22:25:32
Check Details
How to determine whether you are resistant to Osimertinib (Tagrisso)?
2026-02-01 22:25:32
Check Details
Targets targeted by Osimertinib (Tagressa)
2026-02-01 22:25:32
Check Details
What should I do if I have oral ulcers while taking Osimertinib (Tagressa)?
2026-02-01 22:25:32
Check Details
How many years can I take Osimertinib (Tagressa)?
2026-02-01 22:25:32
Check Details
The efficacy and safety of the targeted drug Osimertinib (Tagrisso) in the treatment of non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Medication precautions for patients with osimertinib mesylate (Tagrisso)
2026-02-01 22:25:32
Check Details
1
2
...
695
696
697
698
699
700
701
...
10237
10238
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
2
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
3
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB
4
Pacritinib Drug Contraindications and Precautions
5
Pomalidomide Side Effects, Risk Monitoring, and Precautions
6
Dasatinib for Ph+ Chronic Myeloid Leukemia: Dosage, Administration, and Long-Term Care
7
Obeticholic Acid 5 mg for PBC: Dosage, Risks, and Current Status
8
Acalabrutinib Monotherapy for CLL: What It Can and Cannot Do
9
Bepirovirsen for Chronic HBV Functional Cure: FDA Criteria and B-Well Data
10
After Ibrutinib Resistance: CLL/SLL and MCL Next Steps, Progression vs Intolerance
11
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
12
Quizartinib for FLT3-ITD AML: Induction-Consolidation-Maintenance and QT Monitoring